Trial: 202108127

A Phase 2 Open-Label clinical trial of ADP-A2M4CD8 in subjects with advanced esophageal or esophagogastric junction cancers (surpass-2 study)

Phase

II (Cancer Control)

Principal Investigator

Van Tine, Brian

Disease Site

Esophagus; Stomach

Learn more about this study at: clinicaltrials.gov